PERFORMANCE REPORT FOR MARCH 2024
In March 2024 Bitcoin Halving Volatility Opportunities With crypto markets attracting more institutional attention ahead of the upcoming Bitcoin halving, there are substantial market price swings. We have seen renewed volatility, and EndoTech’s algorithms remain responsive to these new market dynamics. This volatility presents an opportunity for investors to adopt a more alpha-oriented approach to […]
PERFORMANCE REPORT FOR FEBRUARY 2024
In February 2024 Quant Funds Learn About EndoTech’s Unique Multivariate AI Approach Over the past few months, EndoTech’s management has been engaging with different quant funds to discuss Dr. Becker’s unique approach. These conversations have showcased EndoTech’s breakthrough in multivariate AI analysis. The discussions highlight EndoTech platform’s ability to factor in more than 200 AI […]
PERFORMANCE REPORT FOR JANUARY 2024
In January 2024 EndoTech’s AI Models Now Live on Other Asset Classes After over a decade of AI development, EndoTech has started engaging select money managers in other asset classes. Just as EndoTech pioneered institutional-grade AI investments for digital assets, we are now leading the charge for other liquid and leverageable assets. Institutional investors have […]
PERFORMANCE REPORT FOR DECEMBER 2023
In December 2023 Involvement in New Crypto Regulation While working behind the scenes, Dr. Becker and Dmitry Gooshchin actively contribute to enhancing various regulatory frameworks for crypto and digital assets. They consistently advocate for law enforcement and regulatory structures for crypto investments in various media outlets. Recently, Dmitry Gooshchin’s positions were recognized and celebrated in […]
PERFORMANCE REPORT FOR NOVEMBER 2023
In November 2023 Algorithmic Fine-Tuning in Anticipation of ETF Approvals In anticipation of the forthcoming ETF approvals, EndoTech’s algorithmic team is currently fine-tuning its modelling. The expected approvals are anticipated in early 2024 and hinge on the approval of the SEC’s Gary Gensler. If granted, these ETFs are projected to contribute to an upswing in […]
PERFORMANCE REPORT FOR OCTOBER 2023
In October 2023 Enhanced Security and Regulatory Processes EndoTech prides itself on exceeding standard security procedures to ensure the utmost safety of all client funds. We have recently implemented an additional layer of verification to guarantee that all client interactions are verified, and access to funds is protected by the strictest security protocols. EndoTech’s […]
PERFORMANCE REPORT FOR SEPTEMBER 2023
In September 2023 Unveiling Experimental New Algorithms Version 1.2 After months of hard work, Dr. Becker is introducing a new set of algorithms. They will be tested on our company accounts before we make them available to the public. EndoTech, a seasoned software company, is dedicated to ensuring the quality of the final product. We […]
EndoTech Stands Strong in Israel in the Face of Horrendous Brutality
Dear valued partners, employees, customers, In the wake of recent horrific terror attacks on innocent civilians in Israel, we want to convey our unwavering strength and unity with the people of Israel. Firstly, our hearts go out to the grieving families, and our prayers are with them during these dark times. It should be clear […]
PERFORMANCE REPORT FOR AUGUST 2023
In August 2023 Artificial Intelligence Algorithm Studio With the explosion of AI innovations in the past year, we have built our own AI algorithm studio. This is an internal studio to more easily integrate, test, and model new artificial intelligence tools and their impact on our models. This proprietary studio is being used internally to […]
PERFORMANCE REPORT FOR JULY 2023
In July 2023 Artificial Intelligence Advancements Our research team does not take a summer break; instead, we continue to develop our artificial intelligence. Dr. Becker’s quant and development team have strengthened the AI toolkit at their disposal. While the list of AI experts and tools is expansive, some of the recent advancements include optimized use […]
